Co-Occurrence of Acromegaly and Hematological Disorders: A Myth or Common Pathogenic Mechanism
Authors:
Open Access
- 21 July 2017
- journal article
- review article
- Published by S. Karger AG in Integrative Medicine International
- Vol. 4 (1-2) , 94-100
Abstract
Background: Acromegaly is not one disease but an association of clinical, biochemical and radiological features. Altered blood counts are often observed in acromegaly patients. Acromegaly patients presenting with a hematological malignancy are rare. To date, there are several cases that have reported the co-occurrence of these diseases. Summary: The coexistence of the two diseases can be a mere coincidence or may have a common pathogenic mechanism. The rarity of these conditions and the small number of patients makes it difficult to determine the real role of elevated growth hormone and insulin-like growth factor-1 levels in the occurrence of hematological malignancies. Patients with growth hormone (GH) replacement due to GH-deficient acromegaly are at a high risk of developing hematological disorders. Conclusion: In this review, we aim to provide evidence for the correlation between the two disorders.Keywords
This publication has 49 references indexed in Scilit:
- Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort StudyThe Journal of Clinical Endocrinology & Metabolism, 2017
- The genetic background of acromegalyPituitary, 2017
- Assessment of Mean Platelet Volume and its Effect on Disease Control in Patients with AcromegalyClinical Laboratory, 2016
- Evaluation of blood neutrophil to lymphocyte and platelet to lymphocyte ratios according to plasma glucose status and serum insulin-like growth factor 1 levels in patients with acromegalyHuman & Experimental Toxicology, 2015
- Coagulation parameters and platelet function analysis in patients with acromegalyJournal of Endocrinological Investigation, 2015
- Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experienceEndocrine Connections, 2015
- A consensus on the diagnosis and treatment of acromegaly complicationsPituitary, 2012
- Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK)Clinical Endocrinology, 2010
- Growth Hormone Deficiency after Treatment of Acromegaly: A Randomized, Placebo-Controlled Study of Growth Hormone ReplacementThe Journal of Clinical Endocrinology & Metabolism, 2010
- Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in JapanThe Journal of Clinical Endocrinology & Metabolism, 1999